Literature DB >> 21351061

[Assessment of nutritional status of patients with chronic obstructive pulmonary disease (COPD) and the impact of diet on COPD risk].

Dominika Posłuszna1, Anna Doboszyńska.   

Abstract

It is estimated that in patients with COPD malnutrition affects 10-15% of patients with mild to moderate stage of disease and 50% of patients with advanced stage of disease. Available studies indicate that weight loss and muscle mass loss are negative prognostic indicators, therefore early diagnosis of malnutrition seems to be a key measure in the treatment of COPD. In the article the authors discuss and compare the most commonly used methods to assess nutritional status and provide information on the impact of diet on risk of COPD in the future. Nutritional status of patients with COPD is difficult to assess. To date, no published standards are available. Reliable and accurate assessment of nutritional status is essential for planning further care and may contribute to the improvement of nutritional status and contribute positively to the course of the disease.

Entities:  

Mesh:

Year:  2011        PMID: 21351061

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  3 in total

1.  Classification of Exacerbation Frequency in the COPDGene Cohort Using Deep Learning With Deep Belief Networks.

Authors:  Jun Ying; Joyita Dutta; Ning Guo; Chenhui Hu; Dan Zhou; Arkadiusz Sitek; Quanzheng Li
Journal:  IEEE J Biomed Health Inform       Date:  2016-12-21       Impact factor: 5.772

2.  A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem.

Authors:  Bravein Amalakuhan; Lukasz Kiljanek; Arvin Parvathaneni; Michael Hester; Pramil Cheriyath; Daniel Fischman
Journal:  J Community Hosp Intern Med Perspect       Date:  2012-04-30

3.  Dietary Behaviour and Nutrition in Patients with COPD Treated with Long-Term Oxygen Therapy.

Authors:  Dominika Mekal; Aleksandra Czerw; Andrzej Deptala
Journal:  Int J Environ Res Public Health       Date:  2021-12-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.